Supplementary reference
Amorim MR, Zanrosso CW, Magalhães IQ, Pereira SC, Figueiredo A, Emerenciano M, Pinheiro VR, d'Andréa
ML, Orioli IM, Koifman S, Pombo-de-Oliveira MS (2008) MTHFR 677C-->T and 1298A-->C
polymorphisms in children with Down syndrome and acute myeloid leukemia in Brazil. Pediatr Hematol
Oncol 25:744–750
Amigou A, Rudant J, Orsi L, Goujon-Bellec S, Leverger G, Baruchel A, Bertrand Y, Nelken B, Plat G, Michel G,
Haouy S, Chastagner P, Ducassou S, Rialland X, Hémon D, Clavel J (2012) Folic acid supplementation,
MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE). Cancer
Causes Control 23:1265–1277
Alcasabas P, Ravindranath Y, Goyette G, Haller A, Del Rosario L, Lesaca-Medina MY, Darga L, Ostrea EM Jr,
Taub JW, Everson RB (2008) 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the
risk of acute lymphoblastic leukemia (ALL) in Filipino children. Pediatr Blood Cancer 51:178–182
Arslan S, Karadayi S, Yildirim ME, Ozdemir O, Akkurt I (2011) The association between
methylene-tetrahydrofolate reductase gene polymorphism and lung cancer risk. Mol Biol Rep 38:991–996
Ajaz S, Khaliq S, Hashmi A, Naqvi SA, Rizvi SA, Mehdi SQ (2012) Polymorphisms in the methylene
tetrahydrofolate reductase gene and their unique combinations are associated with an increased susceptibility
to the renal cancers. Genet Test Mol Biomarkers 16:346–352
Akilzhanova A, Nurkina Z, Momynaliev K, Ramanculov E, Zhumadilov Z, Rakhypbekov T, Hayashida N,
Nakashima M, Takamura N (2013) Genetic profile and determinants of homocysteine levels in Kazakhstan
patients with breast cancer. Anticancer Res 33:4049–4059
Akram M, Malik FA, Kayani MA (2012) Mutational analysis of the MTHFR gene in breast cancer patients of
Pakistani population. Asian Pac J Cancer Prev 13:1599–1603
Azhar MR, Rahimi Z, Vaisi-Raygani A, Akramipour R, Madani H, Rahimi Z, Parsian A (2012) Lack of association
between MTHFR C677T and A1298C polymorphisms and risk of childhood acute lymphoblastic leukemia in
the Kurdish population from Western Iran. Genet Test Mol Biomarkers 16:198–202
Barbosa CG, Souza CL, de Moura Neto JP, Arruda MDGB, Barreto JH, Reis MG, et al. (2008)
Methylenetetrahydrofolate reductase polymorphisms in myeloid leukemia patients from Northeastern Brazil.
Genet Mol Biol 31:29–32
Beebe-Dimmer JL, Iyer PT, Nriagu JO, Keele GR, Mehta S, Meliker JR, Lange EM, Schwartz AG, Zuhlke
KA, Schottenfeld D, Cooney KA (2012) Genetic variation in glutathione S-transferase omega-1, arsenic
methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a
case–control study. Environ Health 11:43
Bethke L, Webb E, Murray A, Schoemaker M, Feychting M, Lönn S, Ahlbom A, Malmer B, Henriksson R,
Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S,
Dimitropoulou P, Lophatananon A, Swerdlow A, Houlston R (2008) Functional polymorphisms in folate
metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev
17:1195–1202
Boccia S, Gianfagna F, Persiani R, La Greca A, Arzani D, Rausei S, D'ugo D, Magistrelli P, Villari P, Van Duijn
CM, Ricciardi G (2007) Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and
susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers 12:635–644
Berglund M, Enblad G, Turesson I, Edman V, Thunberg U (2009) Folate-metabolizing genes in lymphoma patients
from Sweden. Scand J Immunol 70:408–410
Cui LH, Song Y, Si H, Shen F, Shin MH, Kim HN, Choi JS (2012) Folate metabolism-related gene polymorphisms
and susceptibility to primary liver cancer in North China. Med Oncol 29:1837–1842
Chandy S, Sadananda Adiga MN, Ramachandra N, Krishnamoorthy S, Ramaswamy G, Savithri HS,
Krishnamoorthy L (2010) Association of methylenetetrahydrofolate reductase gene polymorphisms &
colorectal cancer in India. Indian J Med Res 131:659–664
Chen J, Yuan L, Duan YQ, Jiang JQ, Zhang R, Huang ZJ, Xiao XR (2014) Impact of methylenetetrahydrofolate
reductase polymorphisms and folate intake on the risk of gastric cancer and their association with
Helicobacter pylori infection and tumor site. Genet Mol Res 13:9718–9726
Carvalho Barbosa Rde C, Menezes DC, Freire TF, Sales DC, Alencar VH, Rabenhorst SH (2012) Associations of
polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent.
Mol Biol Rep 39:4899–4907
Cai D, Ning L, Pan C, Liu X, Bu R, Chen X, Wang K, Cheng Y, Wu B (2010) Association of polymorphisms in
folate metabolic genes and prostate cancer risk: a case–control study in a Chinese population. J Genet
89:263–267
Cao Y, Miao XP, Huang MY, Deng L, Liang XM, Lin DX, Zeng YX, Shao JY (2010) Polymorphisms of
methylenetetrahydrofolate reductase are associated with a high risk of nasopharyngeal carcinoma in a
smoking population from Southern China. Mol Carcinog 49:928–934
Chan JY, Ugrasena DG, Lum DW, Lu Y, Yeoh AE (2011) Xenobiotic and folate pathway gene polymorphisms and
risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol 29:116–123
Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM (2004) MTHFR C677T and A1298C
polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 13:285–292
Chiusolo P, Reddiconto G, Cimino G, Sica S, Fiorini A, Farina G, Vitale A, Sorà F, Laurenti L, Bartolozzi F, Fazi P,
Mandelli F, Leone G (2004) Methylenetetrahydrofolate reductase genotypes do not play a role in acute
lymphoblastic leukemia pathogenesis in the Italian population. Haematologica 89:139–144
Chen J, Ma J, Stampfer MJ, Palomeque C, Selhub J, Hunter DJ (2002) Linkage disequilibrium between the
677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their
contributions to risk of colorectal cancer. Pharmacogenetics 12:339–342
Cai DW, Liu XF, Bu RG, Chen XN, Ning L, Cheng Y, Wu B (2009) Genetic polymorphisms of MTHFR and
aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in a Chinese population.
J Int Med Res 37:1882–1889
Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL, Wu TY, Sun CA (2006) Genetic polymorphisms of the
methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a
case–control study in Taiwan. Carcinogenesis 27:2295–2300
Chiusolo P, Farina G, Putzulu R, Reddiconto G, Fiorini A, De Stefano V, Rossi E, Palladino M, Leone G, Sica S
(2006) Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological
features of multiple myeloma. Ann Hematol 85:474–477
Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, Albertsen H, Potter JD, Samowitz WS (2007)
Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype
(CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28:1672–1679
Cicek MS, Nock NL, Li L, Conti DV, Casey G, Witte JS (2004) Relationship between methylenetetrahydrofolate
reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.
Cancer Epidemiol Biomarkers Prev 13:1331–1336
Capaccio P, Ottaviani F, Cuccarini V, Cenzuales S, Cesana BM, Pignataro L (2005) Association between
methylenetetrahydrofolate reductase polymorphisms, alcohol intake and oropharyngolaryngeal carcinoma in
northern Italy. J Laryngol Otol 119:371–376
Cao HX, Gao CM, Takezaki T, Wu JZ, Ding JH, Liu YT, Li SP, Su P, Cao J, Hamajima N, Tajima K (2008)
Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer. Asian
Pac J Cancer Prev 9:203–208
Cheng CW, Yu JC, Huang CS, Shieh JC, Fu YP, Wang HW, Wu PE, Shen CY (2008) Polymorphism of cytosolic
serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast
Cancer Res Treat 111:145–155
Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, Teitelbaum SL, Britton JA, Terry MB,
Neugut AI, Santella RM (2005) One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer.
Cancer Res 65:1606–1614
Chang SC, Lin PC, Lin JK, Yang SH, Wang HS, Li AF (2007) Role of MTHFR polymorphisms and folate levels in
different phenotypes of sporadic colorectal cancers. Int J Colorectal Dis 22:483–489
Chen K, Song L, Jin MJ, Fan CH, Jiang QT, Yu WP (2006) Association between genetic polymorphisms in folate
metabolic enzyme genes and colorectal cancer: a nested case–control study. Zhonghua Zhong Liu Za Zhi
28:429–432
de Miranda DO, Barros JE, Vieira MM, Lima EL, Moraes VL, da Silva HA, Garcia HL, Lima CA, Gomes AV,
Santos N, Muniz MT (2014) Reduced folate carrier-1 G80a gene polymorphism is associated with
neuroblastoma's development. Mol Biol Rep 41:5069–5075
de Jonge R, Tissing WJ, Hooijberg JH, Jansen G, Kaspers GJ, Lindemans J, Peters GJ, Pieters R (2009)
Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood
113:2284–2289
de Cássia Carvalho Barbosa R, da Costa DM, Cordeiro DE, Vieira AP, Rabenhorst SH (2012) Interaction of
MTHFR C677T and A1298C, and MTR A2756G gene polymorphisms in breast cancer risk in a population in
Northeast Brazil. Anticancer Res 32:4805–4811
De Re V, Cannizzaro R, Canzonieri V, Cecchin E, Caggiari L, De Mattia E, Pratesi C, De Paoli P, Toffoli G (2010)
MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer. Tumour
Biol 31:23–32
de Lima EL, da Silva VC, da Silva HD, Bezerra AM, de Morais VL, de Morais AL, Cruz RV, Barros MH, Hassan
R, de Freitas AC, Muniz MT (2010) MTR polymorphic variant A2756G and retinoblastoma risk in Brazilian
children. Pediatr Blood Cancer 54:904–908
de Vogel S, Wouters KA, Gottschalk RW, van Schooten FJ, de Goeij AF, de Bruïne AP, Goldbohm RA, van
den Brandt PA, Weijenberg MP, van Engeland M (2009) Genetic variants of methyl metabolizing enzymes
and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
Cancer Epidemiol Biomarkers Prev 18:3086–3096
Delgado-Enciso I, Martínez-Garza SG, Rojas-Martínez A, Espinoza-Gómez F, Canseco-Avila LM, Vidal-Gutiérrez
O, Garza-Leal JG, Barboza-Quintana O, Flores-Gutiérrez JP, Barrera-Saldaña HA, Ortiz-López R (2006) The
effect of MTHFR polymorphisms, pregnancy and first intercourse on cervical cancer in a population from the
Northeastern Mexico. Rev Invest Clin 58:462–469
da Costa Ramos FJ, Cartaxo Muniz MT, Silva VC, Araújo M, Leite EP, Freitas EM, Zanrosso CW, Hatagima A, de
Mello MP, Yunes JA, Marques-Salles Tde J, Santos N, Brandalise SR, Pombo-De-Oliveira MS (2006)
Association between the MTHFR A1298C polymorphism and increased risk of acute myeloid leukemia in
Brazilian children. Leuk Lymphoma 47:2070–2075
Ekiz F, Ormeci N, Coban S, Karabulut HG, Aktas B, Tukun A, Tuncali T, Yüksel O, Alkış N (2012) Association of
methylenetetrahydrofolate reductase C677T-A1298C polymorphisms with risk for esophageal
adenocarcinoma, Barrett's esophagus, and reflux esophagitis. Dis Esophagus 25:437–441
Eussen SJ, Vollset SE, Igland J, Meyer K, Fredriksen A, Ueland PM, Jenab M, Slimani N, Boffetta P, Overvad K,
Tjønneland A, Olsen A, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, Weikert C, Pischon T, Linseisen
J, Kaaks R, Trichopoulou A, Zilis D, Katsoulis M, Palli D, Berrino F, Vineis P, Tumino R, Panico S, Peeters
PH, Bueno-de-Mesquita HB, van Duijnhoven FJ, Gram IT, Skeie G, Lund E, González CA, Martínez C,
Dorronsoro M, Ardanaz E, Navarro C, Rodríguez L, Van Guelpen B, Palmqvist R, Manjer J, Ericson U,
Bingham S, Khaw KT, Norat T, Riboli E (2010) Plasma folate, related genetic variants, and colorectal cancer
risk in EPIC. Cancer Epidemiol Biomarkers Prev 19:1328–1340
Ericson UC, Ivarsson MI, Sonestedt E, Gullberg B, Carlson J, Olsson H, Wirfält E (2009) Increased breast cancer
risk at high plasma folate concentrations among women with the MTHFR 677T allele. Am J Clin Nutr
90:1380–1389
Ergul E, Sazci A, Utkan Z, Canturk NZ (2003) Polymorphisms in the MTHFR gene are associated with breast
cancer. Tumour Biol 24:286–290
El Awady MK, Karim AM, Hanna LS, El Husseiny LA, El Sahar M, Menem HA, Meguid NA (2009)
Methylenetetrahydrofolate reductase gene polymorphisms and the risk of colorectal carcinoma in a sample of
Egyptian individuals. Cancer Biomark 5:233–240
Festa F, Kumar R, Sanyal S, Undén B, Nordfors L, Lindholm B, Snellman E, Schalling M, Försti A, Hemminki K
(2005) Basal cell carcinoma and variants in genes coding for immune response, DNA repair, folate and
iron metabolism. Mutat Res 574:105–111
Franco RF, Simões BP, Tone LG, Gabellini SM, Zago MA, Falcão RP (2001) The methylenetetrahydrofolate
reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J
Haematol 115:616–618
Fernández-Peralta AM, Daimiel L, Nejda N, Iglesias D, Medina Arana V, González-Aguilera JJ (2010) Association
of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic
characteristic of tumors, and response to chemotherapy. Int J Colorectal Dis 25:141–151
Fan yf, Li j, Xu rx, Yang f (2014) Study on the relationship between the MTHFR polymorphism, the level of the
folic acid and the cervical cancer susceptibility. Sichuan Da Xue Xue Bao Yi Xue Ban 45:258–261
Guillem VM, Collado M, Terol MJ, Calasanz MJ, Esteve J, Gonzalez M, Sanzo C, Nomdedeu J, Bolufer P, Lluch
A, Tormo M (2007) Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia
after treatment of breast cancer and hematological malignancies. Leukemia 21:1413–1422
Gemignani F, Landi S, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D,
Foretova L, Janout V, Bencko V, Gaborieau V, Gioia-Patricola L, Bellini I, Barale R, Canzian F, Hall J,
Boffetta P, Hung RJ, Brennan P (2007) Development of lung cancer before the age of 50: the role of
xenobiotic metabolizing genes. Carcinogenesis 28:1287–1293
Gemmati D, Ongaro A, Scapoli GL, Della Porta M, Tognazzo S, Serino ML, Di Bona E, Rodeghiero F, Gilli G,
Reverberi R, Caruso A, Pasello M, Pellati A, De Mattei M (2004) Common gene polymorphisms in the
metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's
lymphoma in adults. Cancer Epidemiol Biomarkers Prev 13:787–794
González-Herrera L, Rodríguez-Morales P, Gonza Lez-Losa Mdel R, Pérez-Mendoza G, Canul-Canché J,
Rosado-López I, Cetina TC (2014) MTHFR/p53 polymorphisms as genetic factors for cervical intraepithelial
neoplasia and cervical cancer in HPV-infected Mexican women. Int J Biol Markers 29:e142–e149
Gra OA, Glotov AS, Nikitin EA, Glotov OS, Kuznetsova VE, Chudinov AV, Sudarikov AB, Nasedkina TV (2008)
Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and
non-Hodgkin's lymphoma in adult Russian patients. Am J Hematol 83:279–287
Gao CM, Kazuo T, Tang JH, Cao HX, Ding JH, Wu JZ, Wang J, Liu YT, Li SP, Su P, Keitaro M, Toshiro T (2009)
MTHFR polymorphisms, dietary folate intake and risks to breast cancer. Zhonghua Yu Fang Yi Xue Za Zhi
43:576–580
Galbiatti AL, da Silva LM, Ruiz-Cintra MT, Raposo LS, Maníglia JV, Pavarino EC, Goloni-Bertollo EM (2012)
Association between 11 genetic polymorphisms in folate-metabolising genes and head and neck cancer risk.
Eur J Cancer 48:1525–1531
González-Fraile MI, García-Sanz R, Mateos MV, Balanzategui A, González M, Váquez L, San Miguel JF (2002)
Methylenetetrahydrofolate reductase genotype does not play a role in multiple myeloma pathogenesis.
Br J Haematol 117:890–892
Guimarães JL, Ayrizono Mde L, Coy CS, Lima CS (2011) Gene polymorphisms involved in folate and methionine
metabolism and increased risk of sporadic colorectal adenocarcinoma. Tumour Biol 32:853–861
Galbiatti AL, Ruiz MT, Rodrigues JO, Raposo LS, Maníglia JV, Pavarino ÉC, Goloni-Bertollo EM (2012)
Polymorphisms and haplotypes in methylenetetrahydrofolate reductase gene and head and neck squamous cell
carcinoma risk. Mol Biol Rep 39:635–643
Gao CM, Toshiro T, Wu JZ, Cao HX, Liu YT, Ding JH, Li SP, Su P, Hu X, Kai HT, Kazuo T (2004) A case–control
study on the polymorphisms of methylenetetrahydrofolate reductase 1298A-->C and susceptibility of
esophageal cancer. Zhonghua Liu Xing Bing Xue Za Zhi 25:341–345
Gao CM, Tang JH, Cao HX, Ding JH, Wu JZ, Wang J, Liu YT, Li SP, Su P, Matsuo K, Takezaki T, Tajima K
(2009) MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women. J Hum Genet
54:414–418
Hatzimichael E, Dasoula A, Benetatos L, Syed N, Dranitsaris G, Crook T, Bourantas K (2010) Study of specific
genetic and epigenetic variables in multiple myeloma. Leuk Lymphoma 51:2270–2274
Hur M, Park JY, Cho HC, Lee KM, Shin HY, Cho HI (2006) Methylenetetrahydrofolate reductase A1298C
genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia
in the Korean population. Clin Lab Haematol 28:154–159
Habib EE, Aziz M, Kotb M (2005) Genetic polymorphism of folate and methionine metabolizing enzymes and
their susceptibility to malignant lymphoma. J Egypt Natl Canc Inst 17:184–192
Han J, Colditz GA, Hunter DJ (2007) Polymorphisms in the MTHFR and VDR genes and skin cancer risk.
Carcinogenesis 28:390–397
Hosseini M, Houshmand M, Ebrahimi A (2011) MTHFR polymorphisms and breast cancer risk. Arch Med Sci
7:134–137
Huang CY, Chang WS, Shui HA, Hsieh YH, Loh CH, Wang HC, Ji HX, Hsiao CL, Hsu CM, Tsai CW, Bau DT
(2014) Evaluation of the contribution of methylenetetrahydrofolate reductase genotypes to Taiwan breast
cancer. Anticancer Res 34:4109–4115
Hung RJ, Hashibe M, McKay J, Gaborieau V, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P,
Fabianova E, Mates I, Foretova L, Janout V, Bencko V, Chabrier A, Moullan N, Canzian F, Hall J, Boffetta P,
Brennan P (2007) Folate-related genes and the risk of tobacco-related cancers in Central Europe.
Carcinogenesis 28:1334–1340
Ismail SI, Ababneh NA, Khader Y, Abu-Khader AA, Awidi A (2009) Methylenetetrahydrofolate reductase
genotype association with the risk of follicular lymphoma. Cancer Genet Cytogenet 195:120–124
Izmirli M, Inandiklioglu N, Abat D, Alptekin D, Demirhan O, Tansug Z, Bayazit Y (2011) MTHFR gene
polymorphisms in bladder cancer in the Turkish population. Asian Pac J Cancer Prev 12:1833–1835
Justenhoven C, Hamann U, Pierl CB, Rabstein S, Pesch B, Harth V, Baisch C, Vollmert C, Illig T, Brüning T, Ko Y,
Brauch H (2005) One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and
TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol Biomarkers Prev
14:3015–3018
Jazbec J, Kitanovski L, Aplenc R, Debeljak M, Dolzan V (2005) No evidence of association of
methylenetetrahydrofolate reductase polymorphism with occurrence of second neoplasms after treatment of
childhood leukemia. Leuk Lymphoma 46:893–897
Jakubowska A, Gronwald J, Menkiszak J, Górski B, Huzarski T, Byrski T, Edler L, Lubiński J, Scott RJ, Hamann
U (2007) Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and
ovarian cancer risks. Breast Cancer Res Treat 104:299–308
Jokić M, Brčić-Kostić K, Stefulj J, Catela Ivković T, Božo L, Gamulin M, Kapitanović S (2011) Association of
MTHFR, MTR, MTRR, RFC1, and DHFR gene polymorphisms with susceptibility to sporadic colon cancer.
DNA Cell Biol 30:771–776
Jiang N, Zhu X, Zhang H, Wang X, Zhou X, Gu J, Chen B, Ren J (2014) The relationship between
methylenetetrahydrofolate reductase polymorphism and hematological malignancy. Clin Lab 60:767–774
Jiang Q, Chen K, Ma X, Li Q, Yu W, Shu G, Yao K (2005) Diets, polymorphisms of methylenetetrahydrofolate
reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev 29:146–154
Jiang QT, Chen K, Ma XY, Miao XP, Yao KY, Yu WP, Li LY, Zhu YM, Zhou HG (2004) A case–control study on
the polymorphisms of methylenetetrahydrofolate reductases, drinking interaction and susceptibility in
colorectal cancer. Zhonghua Liu Xing Bing Xue Za Zhi 25:612–616
Jakubowska A, Jaworska K, Cybulski C, Janicka A, Szymańska-Pasternak J, Lener M, Narod SA, Lubiński J;
IHCC-Breast Cancer Study Group (2009) Do BRCA1 modifiers also affect the risk of breast cancer in
non-carriers? Eur J Cancer 45:837–842
Keku T, Millikan R, Worley K, Winkel S, Eaton A, Biscocho L, Martin C, Sandler R (2002)
5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African
Americans and whites. Cancer Epidemiol Biomarkers Prev 11:1611–1621
Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A, Sinnett D (2004) Role of
MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood
103:252–257
Küry S, Buecher B, Robiou-du-Pont S, Scoul C, Colman H, Le Neel T, Le Houérou C, Faroux R, Ollivry J,
Lafraise B, Chupin LD, Sébille V, Bézieau S (2008) Low-penetrance alleles predisposing to sporadic
colorectal cancers: a French case–controll edgenetic association study. BMC Cancer 8:326
Kim JK, Kim S, Han JH, Kim HJ, Chong SY, Hong SP, Hwang SG, Ahn JY, Cha KY, Oh D, Kim NK (2005)
Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean
population. Anticancer Res 25:2249–2252
Kim NK, Chong SY, Jang MJ, Hong SH, Kim HS, Cho EK, Lee JA, Ahn MJ, Kim CS, Oh D (2006) Association of
the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute
lymphoblastic leukemia. Anticancer Res 26:2879–2881
Kotsopoulos J, Zhang WW, Zhang S, McCready D, Trudeau M, Zhang P, Sun P, Narod SA (2008) Polymorphisms
in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat
112:585–593
Kim HN, Lee IK, Kim YK, Tran HT, Yang DH, Lee JJ, Shin MH, Park KS, Shin MG, Choi JS, Kim HJ (2008)
Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J
Haematol 140:287–294
Kim HN, Kim YK, Lee IK, Lee JJ, Yang DH, Park KS, Choi JS, Park MR, Jo DY, Kim HJ (2007) Polymorphisms
involved in the folate metabolizing pathway and risk of multiple myeloma. Am J Hematol 82:798–801
Karathanasis NV, Stiakaki E, Goulielmos GN, Kalmanti M (2011) The role of the methylenetetrahydrofolate
reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia. Genet Test
Mol Biomarkers 15:5–10
Kim JW, Park HM, Choi YK, Chong SY, Oh D, Kim NK (2011) Polymorphisms in genes involved in folate
metabolism and plasma DNA methylation in colorectal cancer patients. Oncol Rep 25:167–172
Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y (2011) Methylenetetrahydrofolate reductase polymorphisms
and interaction with smoking and alcohol consumption in lung cancer risk: a case-control study in a Japanese
population. BMC Cancer 11:459
Kang S, Kim JW, Kang GH, Park NH, Song YS, Kang SB, Lee HP (2005) Polymorphism in folate- and
methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer.
Gynecol Oncol 96:173–180
Kim HN, Kim YK, Lee IK, Yang DH, Lee JJ, Shin MH, Park KS, Choi JS, Park MR, Jo DY, Won JH, Kwak JY,
Kim HJ (2009) Association between polymorphisms of folate-metabolizing enzymes and hematological
malignancies. Leuk Res 33:82–87
Kasperzyk JL, Chang ET, Birmann BM, Kraft P, Zheng T, Mueller NE (2011) Nutrients and genetic variation
involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case–control study. Am
J Epidemiol 174:816–827
Karagas MR, Park S, Nelson HH, Andrew AS, Mott L, Schned A, Kelsey KT (2005) Methylenetetrahydrofolate
reductase (MTHFR) variants and bladder cancer: a population-based case–control study. Int J Hyg Environ
Health 208:321–327
Kruszyna Ł, Lianeri M, Rydzanicz M, Gajecka M, Szyfter K, Jagodziński PP (2010) Polymorphic variants of
folate metabolism genes and the risk of laryngeal cancer. Mol Biol Rep 37:241–247
Kohaar I, Kumar J, Thakur N, Hussain S, Niyaz MK, Das BC, Sengupta S, Bharadwaj M (2010) Homocysteine
levels are associated with cervical cancer independent of methylene tetrahydrofolate reductase gene
(MTHFR) polymorphisms in Indian population. Biomarkers 15:61–68
Kwak SY, Kim UK, Cho HJ, Lee HK, Kim HJ, Kim NK, Hwang SG (2008) Methylenetetrahydrofolate reductase
(MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular
carcinoma in a Korean population. Anticancer Res 28:2807–2811
Kamel AM, Moussa HS, Ebid GT, Bu RR, Bhatia KG (2007) Synergistic effect of methyltetrahydrofolate
reductase (MTHFR) C677T and A1298Cpolymorphism as risk modifiers of pediatric acute lymphoblastic
leukemia. J Egypt Natl Canc Inst 19:96–105
Koushik A, Kraft P, Fuchs CS, Hankinson SE, Willett WC, Giovannucci EL, Hunter DJ (2006) Nonsynonymous
polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer.
Cancer Epidemiol Biomarkers Prev 15:2408–2417
Kurzwelly D, Knop S, Guenther M, Loeffler J, Korfel A, Thiel E, Hebart H, Simon M, Weller M, Linnebank M,
Herrlinger U (2010) Genetic variants of folate and methionine metabolism and PCNSL incidence in a German
patient population. J Neurooncol 100:187–192
Kang SY, Lee SJ, Hong SH, Chung YK, Oh HS, Kim SW, Yim DJ, Kim NK (2010) Polymorphisms of
5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell
carcinoma of the skin. Mol Med Rep 3:741–747
López-Cortés A, Jaramillo-Koupermann G, Muñoz MJ, Cabrera A, Echeverría C, Rosales F, Vivar N, Paz-Y-Miño
C (2013) Genetic Polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G)
Genes Associated With Pathological Characteristics of Prostate Cancer in the Ecuadorian Population. Am J
Med Sci 346:447–454
Lightfoot TJ, Barrett JH, Bishop T, Northwood EL, Smith G, Wilkie MJ, Steele RJ, Carey FA, Key TJ, Wolf R,
Forman D (2008) Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of
folate in colorectal adenoma, but not colorectal cancer. Cancer Epidemiol Biomarkers Prev 17:2421–2430
Liu Y, Zhou LS, Xu XM, Deng LQ, Xiao QK (2013) Association of Dietary Intake of Folate, Vitamin B6 and B12
and MTHFR Genotype with Breast Cancer Risk. Asian Pac J Cancer Prev 14:5189–5192
Li Q, Lan Q, Zhang Y, Bassig BA, Holford TR, Leaderer B, Boyle P, Zhu Y, Qin Q, Chanock S, Rothman N,
Zheng T (2013) Role of one-carbon metabolizing pathway genes and gene-nutrient interaction in the risk of
non-Hodgkin lymphoma. Cancer Causes Control 24:1875–1884
Lightfoot TJ, Johnston WT, Painter D, Simpson J, Roman E, Skibola CF, Smith MT, Allan JM, Taylor GM (2010)
United Kingdom Childhood Cancer Study. Genetic variation in the folate metabolic pathway and risk of
childhood leukemia. Blood 115:3923–3929
Li R, Wang R, Li Y, Li X, Feng Y, Li Y, Jiang C (2013) Association study on MTHFR polymorphisms and
meningioma in northern China. Gene 516:291–293
Lordelo GS, Miranda-Vilela AL, Akimoto AK, Alves PC, Hiragi CO, Nonino A, Daldegan MB,
Klautau-Guimarães MN, Grisolia CK (2012) Association between methylene tetrahydrofolate reductase and
glutathione S-transferase M1 gene polymorphisms and chronic myeloid leukemia in a Brazilian population.
Genet Mol Res 11:1013–1026
Lajin B, Alhaj Sakur A, Ghabreau L, Alachkar A (2012) Association of polymorphisms in one-carbon metabolizing
genes with breast cancer risk in Syrian women. Tumour Biol 33:1133–1139
Lee JE, Wei EK, Fuchs CS, Hunter DJ, Lee IM, Selhub J, Stampfer MJ, Willett WC, Ma J, Giovannucci E (2012)
Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested
case–control studies. Cancer Causes Control 23:537–545
Li H, Xu WL, Shen HL, Chen QY, Hui LL, Long LL, Zhu XL (2011) Methylenetetrahydrofolate reductase
genotypes and haplotypes associated with susceptibility to colorectal cancer in an eastern Chinese Han
population. Genet Mol Res 10:3738–3746
Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A (2002) B-vitamin intake, metabolic
genes, and colorectal cancer risk (United States). Cancer Causes Control 13:239–248
Lincz LF, Scorgie FE, Kerridge I, Potts R, Spencer A, Enno A (2003) Methionine synthase genetic polymorphism
MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or
multiple myeloma. Br J Haematol 120:1051–1054
Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE (2004) MTHFR polymorphisms, diet,
HRT, and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 13:2071–2077
Li S, Ji M, He N, Lu Z (2007) Application of microarray-based method for methylenetetrahydrofolate reductase
(MTHFR) polymorphisms in the risk of gastric carcinoma in east China population. J Nanosci Nanotechnol
7:3245–3249
Lima CS, Ortega MM, Ozelo MC, Araujo RC, De Souza CA, Lorand-Metze I, Annichino-Bizzacchi JM, Costa FF
(2008) Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR),
methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Leuk
Res 32:401–405
Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock S, Davis S, Blair A, Schenk M, Rothman N, Lan Q
(2007) Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of
non-Hodgkin lymphoma: NCI-SEER case–control study. Blood 109:3050–3059
Liu CS, Tsai CW, Hsia TC, Wang RF, Liu CJ, Hang LW, Chiang SY, Wang CH, Tsai RY, Lin CC, Bau DT (2009)
Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer
patients. Cancer Genomics Proteomics 6:325–329
Lv L, Wu C, Sun H, Zhu S, Yang Y, Chen X, Fu H, Bao L (2010) Combined 677CC/1298AC genotypes of
methylenetetrahydrofolate reductase (MTHFR ) reduce susceptibility to precursor B lymphoblastic leukemia
in a Chinese population. Eur J Haematol 84:506–512
Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL,
Hassan MM (2005) 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic
cancer. Cancer Epidemiol Biomarkers Prev 14:1470–1476
Lima CS, Nascimento H, Bonadia LC, Teori MT, Coy CS, Góes JR, Costa FF, Bertuzzo CS (2007) Polymorphisms
in methylenetetrahydrofolate reductase gene (MTHFR) and the age of onset of sporadic colorectal
adenocarcinoma. Int J Colorectal Dis 22:757–763
Lissowska J, Gaudet MM, Brinton LA, Chanock SJ, Peplonska B, Welch R, Zatonski W, Szeszenia-Dabrowska N,
Park S, Sherman M, Garcia-Closas M (2007) Genetic polymorphisms in the one-carbon metabolism pathway
and breast cancer risk: a population-based case–control study and meta-analyses. Int J Cancer
120:2696–2703
Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, Navarro M, de Oca J, Capellà G,
Canzian F; Bellvitge Colorectal Cancer Study Group (2005) A comprehensive analysis of phase I and phase II
metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 15:535–546
Liu H, Jin G, Wang H, Wu W, Liu Y, Qian J, Fan W, Ma H, Miao R, Hu Z, Sun W, Wang Y, Jin L, Wei Q, Shen H,
Huang W, Lu D (2008) Association of polymorphisms in one-carbon metabolizing genes and lung cancer risk:
a case–control study in Chinese population. Lung Cancer 61:21–29
Lightfoot TJ, Skibola CF, Willett EV, Skibola DR, Allan JM, Coppede F, Adamson PJ, Morgan GJ, Roman E,
Smith MT (2005) Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing
genes. Cancer Epidemiol Biomarkers Prev 14:2999–3003
Lin J, Spitz MR, Wang Y, Schabath MB, Gorlov IP, Hernandez LM, Pillow PC, Grossman HB, Wu X (2004)
Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case–control study.
Carcinogenesis 25:1639–1647
Murtaugh MA, Curtin K, Sweeney C, Wolff RK, Holubkov R, Caan BJ, Slattery ML (2007) Dietary intake of
folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes
Control 18:153–163
Ma E, Iwasaki M, Junko I, Hamada GS, Nishimoto IN, Carvalho SM, Motola J Jr, Laginha FM, Tsugane S (2009)
Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of
breast cancer: a case-control study in Brazilian women. BMC Cancer 9:122
Moore LE, Hung R, Karami S, Boffetta P, Berndt S, Hsu CC, Zaridze D, Janout V, Kollarova H, Bencko V,
Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Yeager M, Chanock S,
Garcia-Closas M, Rothman N, Chow WH, Brennan P (2008) Folate metabolism genes, vegetable intake and
renal cancer risk in central Europe. Int J Cancer 122:1710–1715
Mu LN, Cao W, Zhang ZF, Cai L, Jiang QW, You NC, Goldstein BY, Wei GR, Chen CW, Lu QY, Zhou XF, Ding
BG, Chang J, Yu SZ (2007) Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C
polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer
Causes Control 18:665–675
Mu LN, Cao W, Zhang ZF, Yu SZ, Jiang QW, You NC, Lu QY, Zhou XF, Ding BG, Chang J, Chen CW, Wei GR,
Cai L (2007) Polymorphisms of 5,10-methylenetetralydrofolate reductase (MTHFR), fruit and vegetable\
intake, and the risk of stomach cancer. Biomarkers 12:61–75
Moon HW, Kim TY, Oh BR, Min HC, Cho HI, Bang SM, Lee JH, Yoon SS, Lee DS (2007) MTHFR
677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case–control study in
Korea. Leuk Res 31:1213–1217
Miao X, Xing D, Tan W, Lu W, Lin D (2002) Single nucleotide polymorphisms in methylenetetrahydrofolate
reductase gene and susceptibility to cancer of the gastric cardia in Chinese population. Zhonghua Yi Xue Za
Zhi 82:669–672
Metayer C, Scélo G, Chokkalingam AP, Barcellos LF, Aldrich MC, Chang JS, Guha N, Urayama KY, Hansen
HM, Block G, Kiley V, Wiencke JK, Wiemels JL, Buffler PA (2011) Genetic variants in the folate pathway
and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 22:1243–1258
Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, Kondoh E, Maeda S, Asakura S, Kaba S,
Nakamura S, Seto M, Morishima Y, Tajima K (2001) Association between polymorphisms of folate- and
methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 97:3205–3209
Miao X, Xing D, Tan W, Qi J, Lu W, Lin D (2002) Susceptibility to gastric cardia adenocarcinoma and genetic
polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol
Biomarkers Prev 11:1454–1458
Matsuo K, Hamajima N, Hirai T, Kato T, Inoue M, Takezaki T, Tajima K (2002) Methionine Synthase Reductase
Gene A66G Polymorphism is Associated with Risk of Colorectal Cancer. Asian Pac J Cancer Prev 3:353–359
Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, García-Closas R, Silverman D, Chanock S,
Welch R, Tardón A, Serra C, Carrato A, Dosemeci M, García-Closas M (2007) Polymorphisms in
one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer
120:2452–2458
Manuguerra M1, Matullo G, Veglia F, Autrup H, Dunning AM, Garte S, Gormally E, Malaveille C, Guarrera S,
Polidoro S, Saletta F, Peluso M, Airoldi L, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J,
Boeing H, Trichopoulos D, Kalandidi A, Palli D, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB,
Peeters PH, Lund E, Pera G, Martinez C, Amiano P, Barricarte A, Tormo MJ, Quiros JR, Berglund G, Janzon
L, Jarvholm B, Day NE, Allen NE, Saracci R, Kaaks R, Ferrari P, Riboli E, Vineis P (2007) Multi-factor
dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment
interactions. Carcinogenesis 28:414–422
Marchal C, Redondo M, Reyes-Engel A, Perea-Milla E, Gaitan MJ, Machuca J, Diaz F, Caballero J, Carnero J
(2008) Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. Eur J
Surg Oncol 34:805–810
Moore LE, Wiencke JK, Bates MN, Zheng S, Rey OA, Smith AH (2004) Investigation of genetic polymorphisms
and smoking in a bladder cancer case-control study in Argentina. Cancer Lett 211:199–207
Ma E, Iwasaki M, Kobayashi M, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R, Tsugane S (2009)
Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and
risk of breast cancer: a case–control study in Japan. Nutr Cancer 61:447–456
Muslumanoglu MH, Tepeli E, Demir S, Uludag A, Uzun D, Atli E, Canturk KM, Ozdemir M, Turgut M (2009)
The analysis of the relationship between A1298C and C677T polymorphisms of the MTHFR gene with
prostate cancer in Eskisehir population. Genet Test Mol Biomarkers 13:641–645
Mir MM, Dar JA, Dar NA, Dar MS, Salam I, Lone MM, Chowdary NA (2008) Combined impact of
polymorphism of folate metabolism genes; glutamate carboxypeptidase, methylene tetrahydrofolate reductase
and methionine synthase reductase on breast cancer susceptibility in kashmiri women. Int J Health Sci
(Qassim) 2:3–14
Miao XP, Yang S, Tan W, Zhang XM, Ye YJ, Lin DX, Wang S (2005) Association between genetic variations in
methylenetetrahydrofolate reductase and risk of colorectal cancer in a Chinese population. Zhonghua Yu Fang
Yi Xue Za Zhi 39:409–411
Matsuo K, Ito H, Wakai K, Hirose K, Saito T, Suzuki T, Kato T, Hirai T, Kanemitsu Y, Hamajima H, Tajima K
(2005) One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the
risk of colorectal cancer in Japan. Carcinogenesis 26:2164–2171
Nandan NK, Wajid S, Biswas S, Juneja SS, Rizvi M, Prakash R, Naqvi SH (2008) Allelic variations in 5,
10-methylenetetrahydrofolate reductase gene and susceptibility to cervical cancer in Indian women. Drug
Metab Lett 2:18–22
Niclot S, Pruvot Q, Besson C, Savoy D, Macintyre E, Salles G, Brousse N, Varet B, Landais P, Taupin P, Junien C,
Baudry-Bluteau D (2006) Implication of the folate-methionine metabolism pathways in susceptibility to
follicular lymphomas. Blood 108:278–285
Ni X, Tai J, Ma LJ, Huang ZG, Fang JG, Chen XH, Zhang W, Zhao LP, Lu XX, Han DM (2008) Association
between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of laryngeal squamous cell
carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 43:435–438
Naghibalhossaini F, Mokarram P, Khalili I, Vasei M, Hosseini SV, Ashktorab H, Rasti M, Abdollahi K (2010)
MTHFR C677T and A1298C variant genotypes and the risk of microsatellite instability among Iranian
colorectal cancer patients. Cancer Genet Cytogenet 197:142–151
Nückel H, Frey UH, Dürig J, Dührsen U, Siffert W (2004) Methylenetetrahydrofolate reductase (MTHFR) gene
677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in
vitro and disease progression in chronic lymphocytic leukemia. Leukemia 18:1816–1823
Neumann AS, Lyons HJ, Shen H, Liu Z, Shi Q, Sturgis EM, Shete S, Spitz MR, El-Naggar A, Hong WK, Wei Q
(2005) Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head
and neck: a case–control analysis. Int J Cancer 115:131–136
Nikbakht M, MalekZadeh K, Kumar Jha A, Askari M, Marwaha RK, Kaul D, Kaur J (2012) Polymorphisms of
MTHFR and MTR genes are not related to susceptibility to childhood ALL in North India. Exp Oncol
34:43–48
Nasr AS, Sami RM, Ibrahim NY (2012) Methylenetetrahydrofolate reductase gene polymorphisms (677C > T
and 1298A > C) in Egyptian patients with non-Hodgkin lymphoma. J Cancer Res Ther 8:355–360
Oliveira E, Alves S, Quental S, Ferreira F, Norton L, Costa V, Amorim A, Prata MJ (2005) The MTHFR C677T
and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J
Pediatr Hematol Oncol 27:425–429
Onur E, Kurdal AT, Tugrul B, Iskesen I, Dundar P, Taneli F, Ulman C, Var A (2012) Is genetic screening necessary
for determining the possibility of venous thromboembolism in cancer patients? Med Princ Pract 21:160–163
Ozdemir S, Silan F, Hasbek Z, Uludag A, Atik S, Erselcan T, Ozdemir O (2012) Increased T-allele frequency of
677 C>T polymorphism in the methylenetetrahydrofolate reductase gene in differentiated thyroid
carcinoma. Genet Test Mol Biomarkers 16:780–784
Osian G, Procopciuc L, Vlad L (2007) MTHFR polymorphisms as prognostic factors in sporadic colorectal cancer.
J Gastrointestin Liver Dis 16:251–256
Ouerhani S, Oliveira E, Marrakchi R, Ben Slama MR, Sfaxi M, Ayed M, Chebil M, Amorim A, El Gaaied AB,
Prata MJ (2007) Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of
bladder cancer in a Tunisian population. Cancer Genet Cytogenet 176:48–53
Oh D, Kim NK, Jang MJ, Kim HC, Lee JH, Lee JA, Ahn MJ, Kim CS, Kim HS, Park S, Chio HS, Min YH; HOGS
Investigators (2007) Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and
A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia. Anticancer Res
27:3419–3424
Otani T, Iwasaki M, Hanaoka T, Kobayashi M, Ishihara J, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y,
Yoshimura K, Yoshida T, Tsugane S (2005) Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic
polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case–control study in
Japan. Nutr Cancer 53:42–50
Ouerhani S, Rouissi K, Marrakchi R, Ben Slama MR, Sfaxi M, Chebil M, ElGaaied AB (2009) Combined effect of
NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population.
Cancer Detect Prev 32:395–402
Promthet SS, Pientong C, Ekalaksananan T, Wiangnon S, Poomphakwaen K, Songserm N, Chopjitt P, Moore MA,
Tokudome S (2010) Risk factors for colon cancer in Northeastern Thailand: interaction of MTHFR codon 677
and 1298 genotypes with environmental factors. J Epidemiol 20:329–338
Pardini B, Kumar R, Naccarati A, Prasad RB, Forsti A, Polakova V, Vodickova L, Novotny J, Hemminki K,
Vodicka P (2011) MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in
a case–control study from the Czech Republic. Mutat Res 721:74–80
Plaschke J, Schwanebeck U, Pistorius S, Saeger HD, Schackert HK (2003) Methylenetetrahydrofolate reductase
polymorphisms and risk of sporadic and hereditary colorectal cancer with or without microsatellite instability.
Cancer Lett 191:179–185
Petra BG, Janez J, Vita D (2007) Gene-gene interactions in the folate metabolic pathway influence the risk for
acute lymphoblastic leukemia in children. Leuk Lymphoma 48:786–792
Papandreou CN, Doxani C, Zdoukopoulos N, Vlachostergios PJ, Hatzidaki E, Bakalos G, Ziogas DC, Koufakis T,
Zintzaras E (2012) Evidence of association between methylenetetrahydrofolate reductase gene and
susceptibility to breast cancer: a candidate-gene association study in a South-eastern European population.
DNA Cell Biol 31:193–198
Promthet S, Pientong C, Ekalaksananan T, Songserm N, Poomphakwaen K, Chopjitt P, Wiangnon S, Tokudome S
(2012) Risk factors for rectal cancer and methylenetetrahydrofolate reductase polymorphisms in a population
in Northeast Thailand. Asian Pac J Cancer Prev 13:4017–4023
Paynter RA, Hankinson SE, Hunter DJ, De Vivo I (2004) No association between MTHFR 677 C->T or 1298
A->C polymorphisms and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 13:1088–1089
Patiño-García A, Zalacaín M, Marrodán L, San-Julián M, Sierrasesúmaga L (2009) Methotrexate in pediatric
osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and
reduced folate carrier 1 expression. J Pediatr 154:688–693
Platek ME, Shields PG, Marian C, McCann SE, Bonner MR, Nie J, Ambrosone CB, Millen AE, Ochs-Balcom HM,
Quick SK, Trevisan M, Russell M, Nochajski TH, Edge SB, Freudenheim JL (2009) Alcohol consumption
and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine
methyltransferase in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 18:2453–2459
Pufulete M, Al-Ghnaniem R, Leather AJ, Appleby P, Gout S, Terry C, Emery PW, Sanders TA. (2003) Folate
status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case–control study.
Gastroenterology 124:1240–1248
Qi J, Miao XP, Tan W, Yu CY, Liang G, Lü WF, Lin DX (2004) Association between genetic polymorphisms in
methylenetetrahydrofolate reductase and risk of breast cancer. Zhonghua Zhong Liu Za Zhi 26:287–289
Qu HH, Cui LH, Wang K, Wang P, Song CH, Wang KJ, Zhang JY, Dai LP (2013) The Methylenetetrahydrofolate
Reductase C677T Polymorphism Influences Risk of Esophageal Cancer in Chinese. Asian Pac J Cancer Prev
14:3163–3168
Rai PS, Pai GC, Alvares JF, Bellampalli R, Gopinath PM, Satyamoorthy K (2014) Intraindividual somatic
variations in MTHFR gene polymorphisms in relation to colon cancer. Pharmacogenomics 15:349–359
Rudd MF, Sellick GS, Allinson R, Matutes E, Catovsky D, Houlston RS (2004) MTHFR polymorphisms and risk
of chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 13:2268–2270
Ragasudha PN, Thulaseedharan JV, Wesley R, Jayaprakash PG, Lalitha P, Pillai MR (2012) A case–control
nutrigenomic study on the synergistic activity of folate and vitamin B12 in cervical cancer progression. Nutr
Cancer 64:550–558
Rao GG, Kurien A, Gossett D, Griffith WF, Coleman RL, Muller CY (2006) A case–control study of
methylenetetrahydrofolate reductase polymorphisms in cervical carcinogenesis. Gynecol Oncol.
101:250–254
Rouissi K, Ouerhani S, Oliveira E, Marrakchi R, Cherni L, Ben Othman F, Ben Slama MR, Sfaxi M, Ayed M,
Chebil M, Amorim A, Prata MJ, Benammar Elgaaied A (2009) Polymorphisms in one-carbon metabolism
pathway genes and risk for bladder cancer in a Tunisian population. Cancer Genet Cytogenet 195:43–53
Reddy H, Jamil K (2006) Polymorphisms in the MTHFR gene and their possible association with susceptibility to
childhood acute lymphocytic leukemia in an Indian population. Leuk Lymphoma 47:1333–1339
Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, Spitz MR, Wei Q (2005) Sex differences in risk of lung cancer
associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev
14:1477–1484
Sharp L, Little J, Brockton NT, Cotton SC, Masson LF, Haites NE, Cassidy J (2008) Polymorphisms in the
methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal
cancer: a case–control study in a population with relatively low folate intake. Br J Nutr 99:379–389
Silva RM, Fontes AC, Silva KA, Sant'Ana TA, Ramos FJ, Marques-Salles Tde J, Pombo-de-Oliveira MS, Muniz
MT (2013) Polymorphisms involved in folate metabolism pathways and the risk of the development of
childhood acute leukemia. Genet Test Mol Biomarkers 17:147–152
Shen H, Newmann AS, Hu Z, Zhang Z, Xu Y, Wang L, Hu X, Guo J, Wang X, Wei Q (2005)
Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case–control
analysis in China. Oncol Rep 13:355–360
Song C, Xing D, Tan W, Wei Q, Lin D (2001) Methylenetetrahydrofolate reductase polymorphisms increase risk of
esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61:3272–3275
Shen H, Spitz MR, Wang LE, Hong WK, Wei Q (2001) Polymorphisms of methylene-tetrahydrofolate reductase
and risk of lung cancer: a case–control study. Cancer Epidemiol Biomarkers Prev 10:397–401
Songserm N, Promthet S, Sithithaworn P, Pientong C, Ekalaksananan T, Chopjitt P, Parkin DM (2012) Risk factors
for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet andmethylenetetrahydrofolate
reductase polymorphisms. Cancer Epidemiol 36:e89–e94
Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y, Wang X, Spitz MR, Wei Q (2001) Polymorphisms of
5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case–control
study. Int J Cancer 95:332–336
Sharp L, Little J, Schofield AC, Pavlidou E, Cotton SC, Miedzybrodzka Z, Baird JO, Haites NE, Heys SD, Grubb
DA (2002) Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase
(MTHFR). Cancer Lett 181:65–71
Safarinejad MR, Shafiei N, Safarinejad S (2012) Methylenetetrahydrofolate reductase (MTHFR) gene C677T,
A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour
behaviour in men. Clin Oncol (R Coll Radiol) 24:269–281
Siemianowicz K, Gminski J, Garczorz W, Slabiak N, Goss M, Machalski M, Magiera-Molendowska H (2003)
Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms in patients with small cell and
non-small cell lung cancer. Oncol Rep 10:1341–1344
Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, Taylor PR, Mark SD
(2003) Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in
Linxian, China. Cancer Epidemiol Biomarkers Prev 12:1222–1226
Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, Norming U, Wijkström H, Larsson P, Kumar R, Hemminki K
(2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25:729–734
Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hébert JR, Jin F, Zheng W (2004) MTHFR polymorphisms,
dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol
Biomarkers Prev 13:190–196
Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, Morgan G (1999) Polymorphisms in the
methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults.
Proc Natl Acad Sci U S A 96:12810–12815
Safarinejad MR, Shafiei N, Safarinejad S (2011) Genetic susceptibility of methylenetetrahydrofolate reductase
(MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell
carcinoma in men. Med Oncol 28:S398–S412
Songserm N, Promthet S, Sithithaworn P, Pientong C, Ekalaksananan T, Chopjitt P, Parkin DM (2011) MTHFR
polymorphisms and Opisthorchis viverrini infection: a relationship with increased susceptibility to
cholangiocarcinoma in Thailand. Asian Pac J Cancer Prev 12:1341–1345
Sailasree R, Nalinakumari KR, Sebastian P, Kannan S (2011) Influence of methylenetetrahydrofolate reductase
polymorphisms in oral cancer patients. J Oral Pathol Med 40:61–66
Safarinejad MR, Shafiei N, Safarinejad S (2010) Relationship between three polymorphisms of
methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate
cancer: a case–control study. Prostate 70:1645–1657
Sood S, Das R, Trehan A, Ahluwalia J, Sachdeva MU, Varma N, Bansal D, Marwaha RK (2010)
Methylenetetrahydrofolate reductase gene polymorphisms: association with risk for pediatric acute
lymphoblastic leukemia in north Indians. Leuk Lymphoma 51:928–932
Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Khuhaprema T, Yoshida T (2010) Genetic polymorphisms in folate
and alcohol metabolism and breast cancer risk: a case–control study in Thai women. Breast Cancer Res Treat
123:885–893
Sadananda Adiga MN, Chandy S, Ramachandra N, Appaji L, Aruna Kumari BS, Ramaswamy G, Savithri HS,
Krishnamoorthy L (2010) Methylenetetrahydrofolate reductase gene polymorphisms and risk of acute
lymphoblastic leukemia in children. Indian J Cancer 47:40–45
Semmler A, Simon M, Moskau S, Linnebank M (2008) Polymorphisms of methionine metabolism and
susceptibility to meningioma formation: laboratory investigation. J Neurosurg 108:999–1004
Sirachainan N, Wongruangsri S, Kajanachumpol S, Pakakasama S, Visudtibhan A, Nuchprayoon I, Lusawat A,
Phudhicharoenrat S, Shuangshoti S, Hongeng S (2008) Folate pathway genetic polymorphisms and
susceptibility of central nervous system tumors in Thai children. Cancer Detect Prev 32:72–78
Si PR, Fang DC, Zhang H, Yang LQ, Luo YH, Liao HY (2005) The relationship between
methylenetetrahydrofolate reductase gene polymorphism and microsatellite instability in gastric cancer.
Zhonghua Liu Xing Bing Xue Za Zhi 26:794–799
Schnakenberg E, Mehles A, Cario G, Rehe K, Seidemann K, Schlegelberger B, Elsner HA, Welte KH, Schrappe M,
Stanulla M (2005) Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility
to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Genet 6:23
Singal R, Ferdinand L, Das PM, Reis IM, Schlesselman JJ (2004) Polymorphisms in the methylenetetrahydrofolate
reductase gene and prostate cancer risk. Int J Oncol 25:1465–1471
Suzuki T, Matsuo K, Hasegawa Y, Hiraki A, Wakai K, Hirose K, Saito T, Sato S, Ueda R, Tajima K (2007)
One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cellcarcinoma:
case–control study. Cancer Sci 98:1439–1446
Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, Thun MJ, Calle EE (2007) Association of
polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer
Epidemiol Biomarkers Prev 16:1140–1147
Suzuki T, Matsuo K, Hiraki A, Saito T, Sato S, Yatabe Y, Mitsudomi T, Hida T, Ueda R, Tajima K (2007) Impact of
one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case–control study.
Carcinogenesis 28:1718–1725
Siraj AK, Ibrahim M, Al-Rasheed M, Bu R, Bavi P, Jehan Z, Abubaker J, Murad W, Al-Dayel F, Ezzat A, El-Solh
H, Uddin S, Al-Kuraya K (2007) Genetic polymorphisms of methylenetetrahydrofolate reductase and
promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
Ann Hematol 86:887–895
Skibola CF, Forrest MS, Coppedé F, Agana L, Hubbard A, Smith MT, Bracci PM, Holly EA (2004)
Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood
104:2155–2162
Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, Barnetson RA, Porteous ME, Dunlop MG,
Campbell H (2008) Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers
Prev 17:171–182
Tao MH, Shields PG, Nie J, Marian C, Ambrosone CB, McCann SE, Platek M, Krishnan SS, Xie B, Edge SB,
Winston J, Vito D, Trevisan M, Freudenheim JL (2009) DNA promoter methylation in breast tumors: no
association with genetic polymorphisms in MTHFRand MTR. Cancer Epidemiol Biomarkers Prev.
18:998–1002
Tsai CW, Hsu CF, Tsai MH, Tsou YA, Hua CH, Chang WS, Lin CC, Bau DT (2011) Methylenetetrahydrofolate
reductase (MTHFR) genotype, smoking habit, metastasis and oral cancer in Taiwan. Anticancer Res
31:2395–2399
Toffoli G, Gafà R, Russo A, Lanza G, Dolcetti R, Sartor F, Libra M, Viel A, Boiocchi M (2003)
Methylenetetrahydrofolate reductase 677 C-->T polymorphism and risk of proximal colon cancer in north
Italy. Clin Cancer Res 9:743–748
Takeuchi S, Takeuchi N, Tsukasaki K, Yang Y, Fermin AC, Tomonaga M, Miller CW, Seo H, Koeffler HP (2004)
Methylenetetrahydrofolate reductase genotype does not play a role in adult T-cell leukemia/lymphoma
pathogenesis among human T-lymphotrophic virus type 1 carriers. Leuk Res 28:1039–1041
Tong N, Fang Y, Li J, Wang M, Lu Q, Wang S, Tian Y, Rong L, Sun J, Xu J, Zhang Z (2010)
Methylenetetrahydrofolate reductase polymorphisms, serum methylenetetrahydrofolate reductase levels, and
risk of childhood acute lymphoblastic leukemia in a Chinese population. Cancer Sci 101:782–786
Terry KL, Tworoger SS, Goode EL, Gates MA, Titus-Ernstoff L, Kelemen LE, Sellers TA, Hankinson SE, Cramer
DW (2010) MTHFR polymorphisms in relation to ovarian cancer risk. Gynecol Oncol 119:319–324
Thirumaran RK, Gast A, Flohr T, Burwinkel B, Bartram C, Hemminki K, Kumar R (2005) MTHFR genetic
polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood 106:2590–2591
Tong SY, Kim MK, Lee JK, Lee JM, Choi SW, Friso S, Song ES, Lee KB, Lee JP (2011) Common polymorphisms
in methylenetetrahydrofolate reductase gene are associated with risks of cervical intraepithelial neoplasia and
cervical cancer in women with low serum folate and vitamin B12. Cancer Causes Control 22:63–72
Yang L, Liu L, Wang J, Qiu L, Mi Y, Ma X, Xiao Z (2011) Polymorphisms in folate-related genes: impact on risk
of adult acute lymphoblastic leukemia rather than pediatric in Han Chinese. Leuk Lymphoma
52:1770–1776
Yeoh AE, Lu Y, Chan JY, Chan YH, Ariffin H, Kham SK, Quah TC (2010) Genetic susceptibility to childhood
acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL
Study Group. Leuk Res 34:276–283
Yousef AM, Shomaf M, Berger S, Ababneh N, Bobali Y, Ali D, Al-Hasan S, Diab O, Ismail S (2013) Allele and
Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Colorectal Cancer
among Jordanian Population. Asian Pac J Cancer Prev 14:4559–4565
Yuan JM, Lu SC, Van Den Berg D, Govindarajan S, Zhang ZQ, Mato JM, Yu MC (2007) Genetic polymorphisms
in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular
carcinoma. Hepatology 46:749–758
Yin G, Kono S, Toyomura K, Hagiwara T, Nagano J, Mizoue T, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura
T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H, Imaizumi N (2004)
Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka
Colorectal Cancer Study. Cancer Sci 95:908–913
Ulrich CM, Curtin K, Samowitz W, Bigler J, Potter JD, Caan B, Slattery ML (2005) MTHFR variants reduce the
risk of G:C->A:T transition mutations within the p53 tumor suppressor gene in colon tumors. J Nutr
135:2462–2467
Vollset SE, Igland J, Jenab M, Fredriksen A, Meyer K, Eussen S, Gjessing HK, Ueland PM, Pera G, Sala N,
Agudo A, Capella G, Del Giudice G, Palli D, Boeing H, Weikert C, Bueno-de-Mesquita HB, Carneiro F, Pala
V, Vineis P, Tumino R, Panico S, Berglund G, Manjer J, Stenling R, Hallmans G, Martínez C, Dorronsoro M,
Barricarte A, Navarro C, Quirós JR, Allen N, Key TJ, Bingham S, Linseisen J, Kaaks R, Overvad K,
Tjønneland A, Büchner FL, Peeters PH, Numans ME, Clavel-Chapelon F, Boutron-Ruault MC, Trichopoulou
A, Lund E, Slimani N, Ferrari P, Riboli E, González CA (2007) The association of gastric cancer risk with
plasma folate, cobalamin, andmethylenetetrahydrofolate reductase polymorphisms in the European
Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 16:2416–2424
Van Guelpen BR, Wirén SM, Bergh AR, Hallmans G, Stattin PE, Hultdin J (2006) Polymorphisms of
methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case–control study. Eur J Cancer
Prev 15:46–50
Vineis P, Veglia F, Garte S, Malaveille C, Matullo G, Dunning A, Peluso M, Airoldi L, Overvad K,
Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen JP, Kaaks R, Boeing H, Trichopoulou A, Palli D,
Crosignani P, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Lund E, Gonzalez CA, Martinez C,
Dorronsoro M, Barricarte A, Navarro C, Quiros JR, Berglund G, Jarvholm B, Day NE, Key TJ, Saracci R,
Riboli E, Autrup H (2007) Genetic susceptibility according to three metabolic pathways in cancers of the lung
and bladder and in myeloid leukemias in nonsmokers. Ann Oncol 18:1230–1242
Vaĭner AS, Boiarskikh UA, Voronina EN, Selezneva IA, Sinkina TV, Lazarev AF, Petrova VD, Filipenko ML
(2010) Polymorphic variants of folate metabolizing genes (C677T and A1298C MTHFR, C1420T SHMT1
and G1958A MTHFD) are not associated with the risk of breast cancer in West Siberian Region of Russia.
Mol Biol (Mosk) 44:816–823
Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Stenling R, Riboli E, Winkvist A, Palmqvist R (2006) Low
folate levels may protect against colorectal cancer. Gut 55:1461–1466
Weiwei Z, Liping C, Dequan L (2014) Association between dietary intake of folate, vitamin B6, B12 &
MTHFR, MTR Genotype and breast cancer risk. Pak J Med Sci 30:106–110
Wang ZG, Cui W, Yang LF, Zhu YQ, Wei WH (2014) Association of dietary intake of folate and MTHFR genotype
with breast cancer risk. Genet Mol Res 13:5446–5451
Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF; United Kingdom ChildhoodCancer
Study investigators (2001) Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and
risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A.
98:4004–4009
Weiner AS, Beresina OV, Voronina EN, Voropaeva EN, Boyarskih UA, Pospelova TI, Filipenko ML (2011)
Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin's lymphoma. Leuk Res 35:508–515
Webb PM, Ibiebele TI, Hughes MC, Beesley J, van der Pols JC, Chen X, Nagle CM, Bain CJ, Chenevix-Trench G;
Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group (2011)
Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer. Eur J Clin Nutr
65:1133–1140
Wu XY, Ni J, Xu WJ, Zhou T, Wang X (2012) Interactions between MTHFR C677T-A1298C variants and folic
acid deficiency affect breast cancer risk in a Chinese population. Asian Pac J Cancer Prev 13:2199–2206
Wang J, Gajalakshmi V, Jiang J, Kuriki K, Suzuki S, Nagaya T, Nakamura S, Akasaka S, Ishikawa H, Tokudome S
(2006) Associations between 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 genetic
polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: a case–control
study in an Indian population. Int J Cancer 118:991–997
Wang L, Miao X, Tan W, Lu X, Zhao P, Zhao X, Shan Y, Li H, Lin D (2005) Genetic polymorphisms in
methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. Clin
Gastroenterol Hepatol 3:743–751
Wu HC, Chang CH, Tsai RY, Lin CH, Wang RF, Tsai CW, Chen KB, Yao CH, Chiu CF, Bau DT, Lin CC (2010)
Significant association of methylenetetrahydrofolate reductase single nucleotide polymorphisms with prostate
cancer susceptibility in taiwan. Anticancer Res 30:3573–3577
Weng YR, Sun DF, Fang JY, Gu WQ, Zhu HY (2006) Folate levels in mucosal tissue but not
methylenetetrahydrofolate reductase polymorphisms are associated with gastric carcinogenesis. World J
Gastroenterol 12:7591–7597
Wang M, Zhu H, Fu G, Wang M, Zhang Z, Lu Q, Wang S, Zhang Z (2009) Polymorphisms of
methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case-control
study with meta-analysis. Clin Exp Med 9:9–19
Xu X, Gammon MD, Zhang H, Wetmur JG, Rao M, Teitelbaum SL, Britton JA, Neugut AI, Santella RM, Chen J
(2007) Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based
study. Carcinogenesis 28:1504–1509
Xu WH, Shrubsole MJ, Xiang YB, Cai Q, Zhao GM, Ruan ZX, Cheng JR, Zheng W, Shu XO (2007) Dietary folate
intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women. Cancer
Epidemiol Biomarkers Prev 16:281–287
Zheng MM, Yue LJ, Zhang HH, Yang CL, Xie C (2013) Association of single nucleotide polymorphism of
methylenetetrahydrofolate reductase gene with susceptibility to acute leukemia. Zhonghua Yi Xue Yi Chuan
Xue Za Zhi 30:451–455
Zhang Z, Liu W, Jia X, Gao Y, Hemminki K, Lindholm B (2004) Use of pyrosequencing to detect clinically
relevant polymorphisms of genes in basal cell carcinoma. Clin Chim Acta 342:137–143
Ziva Cerne J, Stegel V, Gersak K, Novakovic S (2011) Lack of association between methylenetetrahydrofolate
reductase genetic polymorphisms and postmenopausal breast cancer risk. Mol Med Rep 4:175–179
Zanrosso CW, Hatagima A, Emerenciano M, Ramos F, Figueiredo A, Félix TM, Segal SL, Giugliani R, Muniz
MT, Pombo-de-Oliveira MS (2006) The role of methylenetetrahydrofolate reductase in acute lymphoblastic
leukemia in a Brazilian mixed population. Leuk Res 30:477–481
Zhang XM, Miao XP, Tan W, Qu SN, Sun T, Zhou YF, Lin DX (2005) Association between genetic
polymorphisms in methylentetrahydrofolate reductase and risk of lung cancer. Zhongguo Yi Xue Ke Xue
Yuan Xue Bao 27:700–703
Zhang FF, Terry MB, Hou L, Chen J, Lissowska J, Yeager M, Zatonski W, Chanock S, Morabia A, Chow WH
(2007) Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol
Biomarkers Prev 16:115–121